$CAPR

$6.10 +$0.36 (6.27%) Close

$CAPR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 58.1M shares outstanding

Who owns CAPR?

By type of holder

Institutions 67.5% Insiders 1.4% Everyone else 31.0%

Concentration Top 10 holders own 43.0%

BlackRock, Inc. 7.1% · Tang Capital Management LLC 7.1%

Institutional ownership

67.5%

+9.4 pts vs last qtr

Institutional holders

168

-9 vs last qtr

Net shares bought

+5.4M

by institutions in Q2 2026

New / sold out

29 / 38

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

State Street Corp +1.2M
Boxer Capital Management, LLC +805.2K

Biggest sellers in Q2 2026

Point72 Asset Management, L.P. −726.5K
Jane Street Group, LLC SOLD OUT −566.1K

Who is planning to sell?

Notices of proposed sale, last 12 months

$7.86M

5 notices from 4 people

Shares covered

282.5K

0.49% of the company

Arranged in advance

97%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Karimah Es Sabar Director 10b5-1 $3.42M
Karen Krasney Officer 10b5-1 $2.08M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+198.5%

+24.45% a year

Each share's claim on the business

−66.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $26.5M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years35% 3–5 years5% 1–3 years11% Under 1 year49%

Quarterly turnover

19.7%

of institutional shares changed hands

Top 10 managers, median time held

4.8 years

Super Investors

Investment managers reporting CAPR on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	4.1M	7.13%	+723.2K (+21.1%)	≤2021	0.0%
Shares held by quarter Peak holding4.1M (Q2'26) Change over 8 quarters+2.4M Share of the company7.130% BlackRock, Inc.'s full portfolio →
TC Tang Capital Management LLC	4.1M	7.05%	+700.0K (+20.6%)	Q4 '25	4.5%
Shares held by quarter Peak holding4.1M (Q2'26) Change over 8 quarters+4.1M Share of the company7.050% Tang Capital Management LLC's full portfolio →

BlackRock, Inc.

4.1M

% of company

7.13%

Change vs last qtr

+723.2K (+21.1%)

Held since

≤2021

Tang Capital Management LLC

4.1M

% of company

7.05%

Change vs last qtr

+700.0K (+20.6%)

Held since

Q4 '25

28 more super investors behind a free account

See every manager holding Capricor Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CAPR on Form N-PORT; together they hold 17.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$52.5M	2.2M	3.75%	0.49%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$39.9M	1.7M	2.85%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$52.5M

% of company

3.75%

% of the fund

0.49%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$39.9M

% of company

2.85%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Capricor Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
ML Marban Linda Insider	521.0K	0.90%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.900% Marban Linda's insider activity →
LF Litvack Frank Insider	200.1K	0.34%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.340% Litvack Frank's insider activity →

Marban Linda

Insider

521.0K

% of company

0.90%

Change vs last qtr

—

Held since

—

Litvack Frank

Insider

200.1K

% of company

0.34%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Capricor Therapeutics, Inc..

Comments